Pioneering Research in E3 Ubiquitin Ligase Biology and Applications to Drug Discovery

Jennifer Johnston discusses how a better understanding of ubiquitin-proteasome system elements can potentially aid neurodegenerative disease therapeutics.

Event Details:Pioneering Research in E3 Ubiquitin Ligase Biology and Applications to Drug DiscoveryDate(s):

LIVE Webinar

Wednesday, September 29, 2021
2:30 - 3:30 PM Eastern Time

Approximately 40% of human diseases may be attributable to defects in the cellular proteostasis machinery, including the ubiquitin-proteasome system. Accumulation of misfolded, damaged, or aggregated proteins can lead to prolonged stress, accumulation of reactive oxygen species, and cell death. In this webinar, brought to you by Bio-Techne, Jennifer Johnston will discuss how her research of ubiquitin-proteasome system elements, including Parkin E3 ligase, is used to diagnose and treat diseases caused by defects in proteostasis pathways.

Topics to be covered

Register Now

Meet the Speaker:

Jennifer Johnston, PhD
Cofounder and CEO
NysnoBio

Sponsored By

Interested in reading more?

39632-tsu-pioneering-research-ubiquitin-ligase-biology-ac-800x560

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!

Join for free today

Already a member? Login Here